• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PERCUFLEX PLUS; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PERCUFLEX PLUS; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M0061752640
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pain (1994)
Event Date 04/16/2022
Event Type  Injury  
Manufacturer Narrative
Study: u0652 double-j registry clinical study.(b)(4).The complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
It was to reported to boston scientific corporation that a two previously implanted percuflex plus ureteral stent was removed from the left and right ureter, performed on (b)(6) 2022 as part of the u0652 double-j registry clinical study.On (b)(6) 2022, the percuflex plus ureteral stent was successfully placed for stone management in the left and right ureter, and the patient was prescribed the discharge medications acetaminophen (tylenol) and narcotic analgesics (opioids).No issues were noted with the device.On (b)(6) 2022, the patient had experienced a left and right flank pain.The patient was given tylenol, ibuprofen, urine sample, and flomax to treat the pain.During the planned stent removal performed on (b)(6) 2022, the percuflex plus ureteral stent was successfully removed from the patient without any difficulty.There were no new device implanted.On (b)(6) 2022 the event was considered resolved.
 
Event Description
Note: this report pertains to the first of two devices that were used in the same procedure.It was to reported to boston scientific corporation that a two previously implanted percuflex plus ureteral stent was removed from the left and right ureter, performed on (b)(6) 2022 as part of the u0652 double-j registry clinical study.On (b)(6) 2022, the percuflex plus ureteral stent was successfully placed for stone management in the left and right ureter, and the patient was prescribed the discharge medications acetaminophen (tylenol) and narcotic analgesics (opioids).No issues were noted with the device.On (b)(6) 2022, the patient had experienced a left and right flank pain.The patient was given tylenol, ibuprofen, urine sample, and flomax to treat the pain.During the planned stent removal performed on (b)(6) 2022, the percuflex plus ureteral stent was successfully removed from the patient without any difficulty.There were no new device implanted.On april 19, 2022 the event was considered resolved.
 
Manufacturer Narrative
Block g3: study: (b)(6) double-j registry clinical study.Block h6: medical problem code e2330 is being used to capture the reportable issue of pain.Patient impact code f2303 captures the reportable event of medication required.Conclusion code d17 is being used in lieu of an adequate conclusion code for device not returned.The complainant indicated that the device was disposed and will not be returned for evaluation; therefore, a problem analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.Block h11: block b6: removed the statement "the patient had a medical history of bowel disease".And moved to block b7 (other relevant history).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCUFLEX PLUS
Type of Device
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
2546 calle primera
alajuela
CS  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key14458841
MDR Text Key292192958
Report Number3005099803-2022-02774
Device Sequence Number1
Product Code FAD
UDI-Device Identifier08714729041191
UDI-Public08714729041191
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K924608
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM0061752640
Device Catalogue Number175-264
Device Lot Number0028264601
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/27/2022
Initial Date FDA Received05/20/2022
Supplement Dates Manufacturer Received08/10/2022
Supplement Dates FDA Received09/02/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/25/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age64 YR
Patient SexMale
-
-